Technion develops non-invasive flow monitor:
This article was originally published in Clinica
Executive Summary
A team of researchers at Technion, the Israeli Institute of Technology in Haifa, has developed a harmless, non-invasive method for quantitative assessment of skin blood-flow. The new technique uses the temperature increase of a patch of thermally insulated skin to calculate flow for evaluating pathological, micro-circulatory changes in hypertension and diabetes for monitoring medical treatments such as drugs or radiotherapy. Most methods of measuring skin blood-flow provide relative information and in the cases of hydrogen and radioactive clearance are invasive and hazardous.
You may also be interested in...
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.